Pain assessment and analgesic use following the implementation of a pain management protocol during IVF: a prospective study - 19/11/26
, Alice Cathelain a, b, Florence Beaucamp c, Virginie Simon b, Maxime Leroy d, Pauline Plouvier b, Chrystele Rubod aHighlights |
• | Following the implementation of a new pain management protocol, higher pain levels were observed, particularly after oocyte retrieval. |
• | Despite the availability of a structured analgesic protocol, uptake of prescribed analgesics remained low, highlighting the challenges of pain management during IVF. |
• | Patients in ENDALGOFIV 2 had higher baseline pain catastrophizing scores, and patients with endometriosis were more likely to take prescribed analgesics during ovarian stimulation. |
Abstract |
Objective |
The ENDALGOFIV 1 study evaluated pain during IVF in patients with and without endometriosis, showing stable pain levels in patients with endometriosis but increased pain in those without endometriosis. Following the implementation of a standardized analgesic protocol, this study aimed to assess pain management in real-life clinical practice by evaluating pain levels and actual analgesic use during IVF, and comparing pain levels with those observed in the ENDALGOFIV 1 study.
Design |
A prospective, monocentric, observational cohort study with a historical control group (ENDALGOFIV 1) was conducted in the Lille University Hospital ART department from January 2023 to March 2024.
Exposure |
Pain assessment questionnaires using validated scales were completed at key points in the IVF course: before starting treatments, at the end of stimulation and on the day of oocyte retrieval.
Main results |
Data from 278 patients in ENDALGOFIV 1 (73 with endometriosis) and 186 patients in ENDALGOFIV 2 (47 with endometriosis) were analyzed. Baseline pain scores were similar between groups, except for higher catastrophizing scores in ENDALGOFIV 2. After oocyte retrieval, pain scores were higher in ENDALGOFIV 2 than in ENDALGOFIV 1 (numeric pain rating score: 3.77 vs. 3.12, p = 0.01). This difference remained significant in patients without endometriosis (3.82 vs. 3.13, p < 0.01), but not in those with endometriosis. During stimulation, analgesic use was numerically higher among patients with endometriosis than among those without endometriosis (34.6% vs. 17.3%, p = 0.097). After retrieval, only half of patients reported taking the prescribed treatment.
Conclusion |
Pain management during IVF remains challenging. Higher pain levels after oocyte retrieval were observed in ENDALGOFIV 2, particularly among patients without endometriosis. However, the low uptake of prescribed analgesics, together with the historical control design, limits the interpretation of these findings and prevents attributing the observed differences solely to the new protocol. These results highlight the importance of assessing actual analgesic use in clinical practice and support the need for more individualized pain management strategies.
Le texte complet de cet article est disponible en PDF.Keywords : pain, endometriosis, in vitro fertilization, infertility, reproduction
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
